|
|
|
Volumn 24, Issue 1, 2005, Pages 95-98
|
|
Clinicopathologic features of primary thyroid lymphoma.
a
a
CANCER HOSPITAL
(China)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CHOP PROTOCOL;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
PREDNISONE;
VINCRISTINE;
ADJUVANT CHEMOTHERAPY;
ADJUVANT THERAPY;
ADULT;
AGED;
ARTICLE;
FEMALE;
FOLLOW UP;
HUMAN;
LARGE CELL LYMPHOMA;
LYMPH NODE METASTASIS;
LYMPHADENECTOMY;
MALE;
METHODOLOGY;
MIDDLE AGED;
MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA;
MULTIMODALITY CANCER THERAPY;
PATHOLOGY;
RETROSPECTIVE STUDY;
SEX DIFFERENCE;
THYROID TUMOR;
THYROIDECTOMY;
ADULT;
AGED;
AGED, 80 AND OVER;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CHEMOTHERAPY, ADJUVANT;
COMBINED MODALITY THERAPY;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
LYMPH NODE EXCISION;
LYMPHATIC METASTASIS;
LYMPHOMA, LARGE-CELL, DIFFUSE;
LYMPHOMA, MUCOSA-ASSOCIATED LYMPHOID TISSUE;
MALE;
MIDDLE AGED;
PREDNISONE;
RADIOTHERAPY, ADJUVANT;
RETROSPECTIVE STUDIES;
SEX FACTORS;
THYROID NEOPLASMS;
THYROIDECTOMY;
VINCRISTINE;
|
|
EID: 33645268109
PISSN: 1000467X
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (2)
|
|
References (0)
|
